Stockreport

Facial Injectable Market Demand to Hit USD 40.4 Billion by 2033 | Globally at 11.1% CAGR [Yahoo! Finance]

Evolus, Inc.  (EOLS) 
Last evolus, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: us.evolis.com/investor-relations
PDF This is driven by factors such as the desire for quick recovery times, minimal discomfort, and less downtime compared to traditional surgical procedures. New York, Feb [Read more]